{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:09:02Z","timestamp":1790845742916,"version":"4.1.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD032290"],"award-info":[{"award-number":["S10OD032290"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023581","name":"National Science Foundation Graduate Research Fellowship Program","doi-asserted-by":"publisher","award":["DGE-2140004"],"award-info":[{"award-number":["DGE-2140004"]}],"id":[{"id":"10.13039\/100023581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["P01AI167966"],"award-info":[{"award-number":["P01AI167966"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93022C00036"],"award-info":[{"award-number":["75N93022C00036"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.celrep.2024.115036","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T08:25:03Z","timestamp":1733473503000},"page":"115036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV"],"prefix":"10.1016","volume":"43","author":[{"given":"Cara W.","family":"Chao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin R.","family":"Sprouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos C.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Catanzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda L.","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Addetia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack T.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Dosey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adian","family":"Valdez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Ravichandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace G.","family":"Hendricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"Ahlrichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Dobbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Hand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boston","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Treichel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Willoughby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra C.","family":"Walls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Leaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph S.","family":"Baric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Veesler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2978-4692","authenticated-orcid":false,"given":"Neil P.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2024.115036_bib1","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/nm.3985","article-title":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence","volume":"21","author":"Menachery","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2024.115036_bib2","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1073\/pnas.1517719113","article-title":"SARS-like WIV1-CoV poised for human emergence","volume":"113","author":"Menachery","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.115036_bib3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115036_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg5567","article-title":"A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus","volume":"15","author":"Tse","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2024.115036_bib5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/cid\/ciab456","article-title":"Novel canine Coronavirus isolated from a hospitalized patient with pneumonia in east Malaysia","volume":"74","author":"Vlasova","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.celrep.2024.115036_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41586-021-04111-z","article-title":"Independent infections of porcine deltacoronavirus among Haitian children","volume":"600","author":"Lednicky","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115036_bib7","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/infdis\/jiac296","article-title":"Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A Critical Component of the NIAID Plan for Pandemic Preparedness","volume":"227","author":"Cassetti","year":"2022","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2024.115036_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101191","article-title":"MERS-CoV Confirmation among 6,873 suspected persons and relevant Epidemiologic and Clinical Features, Saudi Arabia \u2014 2014 to 2019","volume":"41","author":"Ebrahim","year":"2021","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.celrep.2024.115036_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.7326\/M13-2486","article-title":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection","volume":"160","author":"Arabi","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.celrep.2024.115036_bib10","unstructured":"Middle East respiratory syndrome: global summary and assessment of risk - 16 November 2022 https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/364525\/WHO-MERS-RA-2022.1-eng.pdf."},{"key":"10.1016\/j.celrep.2024.115036_bib11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S1473-3099(20)30248-6","article-title":"Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial","volume":"20","author":"Koch","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.celrep.2024.115036_bib12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1473-3099(20)30160-2","article-title":"Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial","volume":"20","author":"Folegatti","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.celrep.2024.115036_bib13","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1473-3099(19)30266-X","article-title":"Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial","volume":"19","author":"Modjarrad","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.celrep.2024.115036_bib14","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.cell.2018.02.054","article-title":"Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines","volume":"172","author":"Rey","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115036_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115036_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature12328","article-title":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26","volume":"500","author":"Lu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115036_bib17","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/cr.2013.92","article-title":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4","volume":"23","author":"Wang","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.celrep.2024.115036_bib18","doi-asserted-by":"crossref","first-page":"E8508","DOI":"10.1073\/pnas.1712592114","article-title":"Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein","volume":"114","author":"Li","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.115036_bib19","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s41594-019-0334-7","article-title":"Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors","volume":"26","author":"Park","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.celrep.2024.115036_bib20","doi-asserted-by":"crossref","first-page":"7712","DOI":"10.1038\/ncomms8712","article-title":"Evaluation of candidate vaccine approaches for MERS-CoV","volume":"6","author":"Wang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.115036_bib21","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/22221751.2019.1597644","article-title":"Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein","volume":"8","author":"Widjaja","year":"2019","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.celrep.2024.115036_bib22","doi-asserted-by":"crossref","first-page":"10473","DOI":"10.1073\/pnas.1510199112","article-title":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus","volume":"112","author":"Corti","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.115036_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008140","article-title":"Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein","volume":"6","author":"Jiang","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2024.115036_bib24","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/cr.2015.113","article-title":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein","volume":"25","author":"Li","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.celrep.2024.115036_bib25","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1038\/s41467-019-10897-4","article-title":"Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.115036_bib26","doi-asserted-by":"crossref","first-page":"E2018","DOI":"10.1073\/pnas.1402074111","article-title":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution","volume":"111","author":"Tang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.115036_bib27","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1016\/j.celrep.2019.08.052","article-title":"Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTD","volume":"28","author":"Wang","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.115036_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109929","article-title":"Stabilized coronavirus spike stem elicits a broadly protective antibody","volume":"37","author":"Hsieh","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.115036_bib29","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s41564-022-01155-3","article-title":"Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2","volume":"7","author":"Sun","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.celrep.2024.115036_bib30","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.83710","article-title":"Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses","volume":"12","author":"Silva","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2024.115036_bib31","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41594-021-00596-4","article-title":"Structural basis for broad coronavirus neutralization","volume":"28","author":"Sauer","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.celrep.2024.115036_bib32","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1126\/science.abj3321","article-title":"Broad betacoronavirus neutralization by a stem helix-specific human antibody","volume":"373","author":"Pinto","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.115036_bib33","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41467-021-21968-w","article-title":"A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.115036_bib34","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.immuni.2023.02.005","article-title":"Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease","volume":"56","author":"Zhou","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2024.115036_bib35","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s42003-022-03262-7","article-title":"Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit","volume":"5","author":"Hurlburt","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.celrep.2024.115036_bib36","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.abq2679","article-title":"ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies","volume":"377","author":"Low","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.115036_bib37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s42522-022-00068-9","article-title":"Protective efficacy of an RBD-based Middle East respiratory syndrome coronavirus (MERS-CoV) particle vaccine in llamas","volume":"4","author":"Rodon","year":"2022","journal-title":"One Health Outlook"},{"key":"10.1016\/j.celrep.2024.115036_bib38","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1080\/22221751.2020.1760735","article-title":"Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV","volume":"9","author":"Okba","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.celrep.2024.115036_bib39","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1038\/s41467-023-41661-4","article-title":"Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgenera","volume":"14","author":"Hutchinson","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.115036_bib40","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.115036_bib41","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.vaccine.2014.04.016","article-title":"Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice","volume":"32","author":"Coleman","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2024.115036_bib42","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115036_bib43","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.cell.2020.11.032","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"183","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115036_bib44","article-title":"Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation","author":"Wrapp","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2024.115036_bib45","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/s41551-020-00658-w","article-title":"Development of vaccines and antivirals for combating viral pandemics","volume":"4","author":"Pardi","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.celrep.2024.115036_bib46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2024.115036_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102140","article-title":"Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial","volume":"64","author":"Song","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.celrep.2024.115036_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101569","article-title":"Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1\/2 trial","volume":"51","author":"Song","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.celrep.2024.115036_bib49","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.immuni.2023.08.011","article-title":"Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumoviruses","volume":"56","author":"Ols","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2024.115036_bib50","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.cell.2019.01.046","article-title":"Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus","volume":"176","author":"Marcandalli","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115036_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009169","article-title":"Rationally designed Human Cytomegalovirus gB nanoparticle vaccine with improved immunogenicity","volume":"16","author":"Perotti","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2024.115036_bib52","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1038\/s41467-019-12080-1","article-title":"Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle","volume":"10","author":"Brouwer","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.115036_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008665","article-title":"Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens","volume":"16","author":"Antanasijevic","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2024.115036_bib54","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1038\/s41467-022-34961-8","article-title":"Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate","volume":"13","author":"Sliepen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.115036_bib55","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.chom.2022.10.018","article-title":"Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection","volume":"30","author":"Brouwer","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2024.115036_bib56","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41586-021-03365-x","article-title":"Quadrivalent influenza nanoparticle vaccines induce broad protection","volume":"592","author":"Boyoglu-Barnum","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115036_bib57","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1021\/acsnano.0c08379","article-title":"Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates","volume":"15","author":"Kang","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.celrep.2024.115036_bib58","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41541-021-00330-7","article-title":"Protein-based antigen presentation platforms for nanoparticle vaccines","volume":"6","author":"Nguyen","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.celrep.2024.115036_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110217","article-title":"Mannose-binding lectin and complement mediate follicular localization and enhanced immunogenicity of diverse protein nanoparticle immunogens","volume":"38","author":"Read","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.115036_bib60","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41541-020-00223-1","article-title":"Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations","volume":"5","author":"Martin","year":"2020","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.celrep.2024.115036_bib61","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1126\/science.aaf8818","article-title":"Accurate design of megadalton-scale two-component icosahedral protein complexes","volume":"353","author":"Bale","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.115036_bib62","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.cell.2020.10.043","article-title":"Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2","volume":"183","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115036_bib63","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41541-022-00472-2","article-title":"Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice","volume":"7","author":"Grigoryan","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.celrep.2024.115036_bib64","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41586-021-03530-2","article-title":"Adjuvanting a subunit COVID-19 vaccine to induce protective immunity","volume":"594","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115036_bib65","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1016\/j.cell.2021.09.015","article-title":"Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines","volume":"184","author":"Walls","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115036_bib66","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57659","article-title":"Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens","volume":"9","author":"Ueda","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2024.115036_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105649","article-title":"Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses","volume":"25","author":"Brinkkemper","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.celrep.2024.115036_bib68","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cell.2021.01.035","article-title":"Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection","volume":"184","author":"Brouwer","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115036_bib69","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1038\/s41467-022-30222-w","article-title":"Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants","volume":"13","author":"Kang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.115036_bib70","article-title":"Cryoelectron microscopy structures of a human neutralizing antibody bound to MERS-CoV spike glycoprotein","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.celrep.2024.115036_bib71","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.immuni.2020.06.001","article-title":"Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation","volume":"53","author":"Seydoux","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2024.115036_bib72","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.115036_bib73","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.immuni.2018.07.009","article-title":"Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization","volume":"49","author":"Bianchi","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2024.115036_bib74","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn2911","article-title":"Structural mapping of antibody landscapes to human betacoronavirus spike proteins","volume":"8","author":"Bangaru","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2024.115036_bib75","article-title":"Immunization with a self-assembling nanoparticle vaccine displaying EBV gH\/gL protects humanized mice against lethal viral challenge","volume":"3","author":"Malhi","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.celrep.2024.115036_bib76","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.immuni.2020.08.001","article-title":"Multifaceted Effects of Antigen Valency on B Cell Response Composition and Differentiation In\u00a0Vivo","volume":"53","author":"Kato","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2024.115036_bib77","doi-asserted-by":"crossref","first-page":"710263","DOI":"10.3389\/fimmu.2021.710263","article-title":"Stabilization of the SARS-CoV-2 Spike receptor-binding domain using deep mutational scanning and structure-based design","volume":"12","author":"Ellis","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.celrep.2024.115036_bib78","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nsmb.3267","article-title":"Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV","volume":"23","author":"Joyce","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.celrep.2024.115036_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-022-00446-4","article-title":"High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimers","volume":"7","author":"del Moral-S\u00e1nchez","year":"2022","journal-title":"npj Vaccines"},{"key":"10.1016\/j.celrep.2024.115036_bib80","article-title":"Combinatorial Immune Refocusing within the Influenza Hemagglutinin Head Elicits Cross-Neutralizing Antibody Responses.","author":"Dosey","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2024.115036_bib81","article-title":"Antigen spacing on protein nanoparticles influences antibody responses to vaccination","author":"Ellis","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2024.115036_bib82","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.immuni.2022.07.015","article-title":"Vaccination with a structure-based stabilized version of malarial antigen Pfs48\/45 elicits ultra-potent transmission-blocking antibody responses","volume":"55","author":"McLeod","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2024.115036_bib83","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","article-title":"Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site","volume":"162","author":"Kanekiyo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115036_bib84","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41590-018-0305-x","article-title":"Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses","volume":"20","author":"Kanekiyo","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2024.115036_bib85","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.1234150","article-title":"Rational HIV immunogen design to target specific germline B cell receptors","volume":"340","author":"Jardine","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.115036_bib86","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.chom.2021.03.005","article-title":"Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite","volume":"29","author":"Cerutti","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2024.115036_bib87","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-020-2571-7","article-title":"Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike","volume":"584","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115036_bib88","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.cell.2021.03.028","article-title":"N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2","volume":"184","author":"McCallum","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115036_bib89","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41586-021-03807-6","article-title":"SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape","volume":"597","author":"Starr","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115036_bib90","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.cell.2020.11.031","article-title":"Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion","volume":"183","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115036_bib91","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc8413","article-title":"The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients","volume":"5","author":"Premkumar","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2024.115036_bib92","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology","volume":"183","author":"Piccoli","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115036_bib93","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/s41467-017-01706-x","article-title":"Receptor-binding loops in alphacoronavirus adaptation and evolution","volume":"8","author":"Wong","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.115036_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114530","article-title":"Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans","volume":"43","author":"Addetia","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.115036_bib95","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.chom.2020.07.002","article-title":"Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike","volume":"28","author":"Huo","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2024.115036_bib96","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1126\/science.abg9175","article-title":"mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"372","author":"Stamatatos","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.115036_bib97","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abi9915","article-title":"Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection","volume":"13","author":"Greaney","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2024.115036_bib98","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adf1421","article-title":"SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines","volume":"7","author":"Bowen","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2024.115036_bib99","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115036_bib100","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.virol.2017.12.006","article-title":"Adaptive evolution influences the infectious dose of MERS-CoV necessary to achieve severe respiratory disease","volume":"517","author":"Douglas","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.celrep.2024.115036_bib101","doi-asserted-by":"crossref","first-page":"16226","DOI":"10.1038\/nmicrobiol.2016.226","article-title":"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome","volume":"2","author":"Cockrell","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.celrep.2024.115036_bib102","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2106845118","article-title":"Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice","volume":"118","author":"Dalvie","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.115036_bib103","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41467-020-20654-7","article-title":"A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses","volume":"12","author":"Tan","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.115036_bib104","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.abf6840","article-title":"Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice","volume":"371","author":"Cohen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.115036_bib105","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2106433118","article-title":"Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques","volume":"118","author":"King","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.115036_bib106","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-021-03594-0","article-title":"Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses","volume":"594","author":"Saunders","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115036_bib107","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1038\/s41467-023-37417-9","article-title":"A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates","volume":"14","author":"Weidenbacher","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.115036_bib108","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41467-020-20251-8","article-title":"Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity","volume":"12","author":"Fougeroux","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.115036_bib109","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.abe1502","article-title":"Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate","volume":"370","author":"Bangaru","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.115036_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113248","article-title":"Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in mice","volume":"42","author":"Martinez","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.115036_bib111","doi-asserted-by":"crossref","DOI":"10.1126\/science.abq0839","article-title":"Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models","volume":"377","author":"Cohen","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.115036_bib112","article-title":"Mosaic RBD Nanoparticles Elicit Protective Immunity Against Multiple Human Coronaviruses in Animal Models","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.celrep.2024.115036_bib115","article-title":"Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions","author":"Pierre","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2024.115036_bib116","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41564-023-01359-1","article-title":"Fc-\u03b3R-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2","volume":"8","author":"Mackin","year":"2023","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.celrep.2024.115036_bib117","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41586-023-06487-6","article-title":"Neutralization, effector function and immune imprinting of Omicron variants","volume":"621","author":"Addetia","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115036_bib118","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.cell.2021.02.026","article-title":"Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection","volume":"184","author":"Winkler","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115036_bib119","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201993","article-title":"Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in\u00a0vivo","volume":"218","author":"Sch\u00e4fer","year":"2021","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2024.115036_bib120","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1016\/j.cell.2021.07.027","article-title":"Tackling COVID-19 with neutralizing monoclonal antibodies","volume":"184","author":"Corti","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115036_bib121","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","volume":"588","author":"Barnes","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115036_bib122","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02002-17","article-title":"Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape","volume":"92","author":"Wang","year":"2018","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2024.115036_bib123","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1038\/emi.2017.50","article-title":"A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein","volume":"6","author":"Chen","year":"2017","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.celrep.2024.115036_bib124","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.abi7994","article-title":"SARS-CoV-2 immune evasion by the B.1.427\/B.1.429 variant of concern","volume":"373","author":"McCallum","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.115036_bib125","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1126\/science.abl8506","article-title":"Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants","volume":"374","author":"McCallum","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.115036_bib126","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.abn8652","article-title":"Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement","volume":"375","author":"McCallum","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.115036_bib127","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41467-021-21251-y","article-title":"Complete and cooperative in\u00a0vitro assembly of computationally designed self-assembling protein nanomaterials","volume":"12","author":"Wargacki","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.115036_bib128","doi-asserted-by":"crossref","DOI":"10.1126\/science.abn8934","article-title":"Low protease activity in B cell follicles promotes retention of intact antigens after immunization","volume":"379","author":"Aung","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.115036_bib129","article-title":"A stabilized MERS-CoV spike ferritin nanoparticle vaccine elicits robust and protective neutralizing antibody responses","author":"Powell","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2024.115036_bib130","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1126\/science.aat9120","article-title":"Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers","volume":"363","author":"Tokatlian","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.115036_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113553","article-title":"Combinatorial immune refocusing within the influenza hemagglutinin RBD improves cross-neutralizing antibody responses","volume":"42","author":"Dosey","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.115036_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114708","article-title":"Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responses","volume":"43","author":"Brouwer","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.115036_bib133","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh2791","article-title":"Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization","volume":"7","author":"Turner","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2024.115036_bib134","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41586-024-07901-3","article-title":"Farmed fur animals harbour viruses with zoonotic spillover potential","volume":"634","author":"Zhao","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115036_bib135","article-title":"ACE2 from Pipistrellus abramus bats is a receptor for HKU5 coronaviruses","author":"Catanzaro","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2024.115036_bib136","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20043702","article-title":"Identification and genetic characterization of MERS-related Coronavirus isolated from Nathusius\u2019 pipistrelle (Pipistrellus nathusii) near zvenigorod (Moscow Region, Russia)","volume":"20","author":"Speranskaya","year":"2023","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.celrep.2024.115036_bib137","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"Punjani","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2024.115036_bib138","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.celrep.2024.115036_bib139","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pro.3235","article-title":"UCSF ChimeraX: Meeting modern challenges in visualization and analysis","volume":"27","author":"Goddard","year":"2018","journal-title":"Protein Sci."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724013871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724013871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T21:35:10Z","timestamp":1774301710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124724013871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":137,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2211124724013871"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2024.115036","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.03.13.584735","asserted-by":"object"}]},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2024.115036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115036"}}